20Jun/13

Two Studies Evaluating the Combination of REVLIMID(R) and rituximab in Non … – MarketWatch (press release)

Two Studies Evaluating the Combination of REVLIMID(R) and rituximab in Non
MarketWatch (press release)
Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) , today announced that results from two studies evaluating the combination of REVLIMID(R) (lenalidomide) and rituximab in various non-Hodgkin’s lymphomas 
Two Studies Evaluating the Combination of REVLIMID ® and rituximab in Non EON: Enhanced Online News (press release)

all 3 news articles »

20Jun/13

India Floods: Up To 1000 Feared Dead – Heart


India Today

India Floods: Up To 1000 Feared Dead
Heart
At least 1,000 people may have died in flash floods and landslides in the north of India, officials have said. The news comes as India’s army military increases its efforts to reach tourists and pilgrims in villages and towns cut off by torrential
Uttarakhand in misery, eye-witnessess recount the horrific incidentIndia Today
Tales of woe pour in from disaster-struck regionsThe Hindu
Uttarakhand toll mounts to 150, thousands of pilgrims remain strandedTimes of India

all 769 news articles »